Anatara Lifesciences Ltd
Anatara Lifesciences Ltd
Your view on ANR.AX
Overview
What the company does, where it operates, and who runs it.
About Anatara Lifesciences Ltd
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- David Lionel Brookes
- Headquarters
- 62 Lygon Street, Adelaide, SA, AU
- Industry
- Biotechnology
- Sector
- Healthcare
- CEO
- David Lionel Brookes
- Headquarters
- 62 Lygon Street, Adelaide, SA, AU
Anatara Lifesciences Ltd is an Australian enterprise focused on researching, developing, and commercializing scientifically-validated therapies for digestive system ailments affecting both humans and animals.
Its product portfolio includes Gastrointestinal ReProgramming (GRP), a proprietary blend combining bromelain with other evidence-based ingredients, specifically formulated to target the underlying issues of human gastrointestinal conditions such as irritable bowel syndrome and inflammatory bowel disease.
The firm also offers 3FDC, designed to address anxiety, stress, or depression. In the animal health sector, Anatara provides Detach for treating diarrhea in piglets, BONIFF as an enhanced dry feed formulation for weaned piglets, and ANR-pf, a unique additive for poultry drinking water.
This company was founded in 2010 and is headquartered in Carlton, Australia.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Anatara Lifesciences Ltd. Starting points for Anatara Lifesciences Ltd: beta 0.70 — an Biotechnology name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Anatara Lifesciences Ltd. Anatara Lifesciences Ltd does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Anatara Lifesciences Ltd. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterJun 2016 | Next quarterJun 2017 | This yearYear to Jun 2016 | Next yearYear to Jun 2017 |
|---|---|---|---|---|
| Average estimate | −AUD 0.03 | −AUD 0.05 | −AUD 0.02 | −AUD 0.04 |
| Lowest estimate | −AUD 0.03 | −AUD 0.05 | −AUD 0.02 | −AUD 0.04 |
| Highest estimate | −AUD 0.02 | −AUD 0.04 | −AUD 0.02 | −AUD 0.04 |
| Number of analysts | 2 | 3 | 1 | 1 |
| A year ago | — | — | — | — |
| Growth vs a year ago | — | — | — | — |
Revenue estimates
| Total | This quarterJun 2016 | Next quarterJun 2017 | This yearYear to Jun 2016 | Next yearYear to Jun 2017 |
|---|---|---|---|---|
| Average estimate | AUD 1.18M | AUD 1.79M | AUD 1.00M | AUD 1.75M |
| Lowest estimate | AUD 1.13M | AUD 970000.00 | AUD 1.00M | AUD 1.75M |
| Highest estimate | AUD 1.19M | AUD 2.58M | AUD 1.00M | AUD 1.75M |
| Number of analysts | 2 | 3 | 1 | 1 |
| A year ago | — | — | — | — |
| Growth vs a year ago | — | — | — | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Anatara Lifesciences Ltd. Anatara Lifesciences Ltd has reported as a listed company since 2014. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| 1AD.AXAdAlta Limited | Healthcare | Biotechnology | — | ||
| ACR.AXAcrux Limited | Healthcare | Biotechnology | — | ||
| BIT.AXBiotron Limited | Healthcare | Biotechnology | — | ||
| CTQ.AXCareteq Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| EXL.AXElixinol Wellness Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| IBX.AXImagion Biosystems Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| OAK.AXOakridge International Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| OSX.AXOsteopore Limited | Healthcare | Medical - Instruments & Supplies | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| PRTCYPureTech Health plc | Healthcare | OTC | — | ||
| PRVCFPreveCeutical Medical Inc. | Healthcare | OTC | $10.1M | ||
| PSYBFPsyBio Therapeutics Corp. | Healthcare | OTC | $1,275 | ||
| PTCHFPureTech Health plc | Healthcare | OTC | $410.4M | ||
| PTCTPTC Therapeutics, Inc. | Healthcare | NASDAQ | $5.0B | ||
| PTGXProtagonist Therapeutics, Inc. | Healthcare | NASDAQ | $8.3B | ||
| PTHSPelthos Therapeutics Inc. | Healthcare | AMEX | $27.9M | ||
| PTIXProtagenic Therapeutics, Inc. | Healthcare | NASDAQ | $470,654 | ||
| PTNPalatin Technologies, Inc. | Healthcare | NASDAQ | $9.2M | ||
| PTX.AXPrescient Therapeutics Limited | Healthcare | ASX | — | ||
| PULMPulmatrix, Inc. | Healthcare | NASDAQ | $4.9M | ||
| PVCTProvectus Biopharmaceuticals, Inc. | Healthcare | OTC | $18.7M | ||

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Anatara Lifesciences Ltd.